Медицинская библиотека · Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2010

[Expressions of surviving, MMP2, TIMP1, CD44 and nm23 of two tumors originating from different immunosurveillance in the same patient].

Li Hui-ling, Xiang Zheng, Zhao Tong

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To explore the differences in the survival, adhesion and diffusion capacity between different carcinomas originating from different immunosurveillance in the same patient.

METHODS

The expressions of survivin, MMP2, TIMP1, CD44, and nm23 proteins were detected immunohistochemically in a patient with acute lymphoblastic leukemia and lymphoma after allogeneic blood stem cell transplantation.

RESULTS

Survivin, MMP2, TIMP1, CD44, and nm23 proteins were positive in acute lymphoblastic leukemia samples obtained before transplantation and negative in the lymphoma tissue occurring after the transplantation.

CONCLUSION

The expressions of survivin, MMP2, TIMP1, CD44, and nm23 proteins vary between the two carcinomas originating from different immunosurveillance in the same patient.

Для цитирования: Li Hui-ling, Xiang Zheng, Zhao Tong. [Expressions of surviving, MMP2, TIMP1, CD44 and nm23 of two tumors originating from different immunosurveillance in the same patient].. Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 2010.

Предметные рубрики MeSH

Adult Female Hematopoietic Stem Cell Transplantation Humans Hyaluronan Receptors Inhibitor of Apoptosis Proteins Lymphoma, Large B-Cell, Diffuse Matrix Metalloproteinase 2 NM23 Nucleoside Diphosphate Kinases Neoplasms, Second Primary Precursor Cell Lymphoblastic Leukemia-Lymphoma Survivin Tissue Inhibitor of Metalloproteinase-1

Подготовка и перевод публикации

Обработка статьи · этапы, ошибки и управление

Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.